Buy Ambuja Cements; target of Rs 600: Motilal Oswal

BUY

Motilal Oswal's research report on Ambuja Cements

Ambuja Cements (ACEM)’s 3QFY25 consolidated EBITDA (adjusted for prior period incentives of INR8.3b) declined ~49% YoY to INR8.9b (-35% vs. est.), due to weak realization and higher opex/t (up to INR100-150/t related to acquired assets that are in the transition and ramp-up phase). EBITDA/t declined 56% YoY to INR537 (est. INR848). PAT (adjusted for the reversal of tax provisions) declined 50% YoY to INR4.1b (-28% vs. our estimate). Management indicated consol. volume growth of ~17% YoY, with ~10% of this growth driven by two major inorganic expansions (Sanghi and Penna Cement). Currently, both companies are in the transition and ramp-up phase, and the company is implementing various cost-reduction initiatives. It expects plant capacity utilization for both companies to increase 70%+ in FY26 vs. sub-40% utilization currently.

Outlook

We also reduce our valuation multiple to 18x EV/EBITDA (vs. 20x earlier), a 10% discount to UTCEM. ACEM (consol.) trades at 20x/15x FY26/FY27E EV/EBITDA. We maintain our BUY rating with a revised TP of INR600 (earlier INR750).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Ambuja Cements_30012025_Motilal Oswal